📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Itaconate controls the severity of pulmonary fibrosis. (2020)

First Author: Ogger PP

Attributed to: Imperial College London – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/sciimmunol.abc1884

PubMed Identifier: 33097591

Publication URI: http://europepmc.org/abstract/MED/33097591

Type: Journal Article/Review

Volume: 5

Parent Publication: Science immunology

Issue: 52

ISSN: 2470-9468